These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 23282552

  • 1. [Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Ferrés M, Nervi B, Ramírez P.
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S23-8. PubMed ID: 23282552
    [Abstract] [Full Text] [Related]

  • 2. Management of CMV infection and disease in transplant patients. 27-29 February 2004.
    Razonable RR, Emery VC, 11th Annual Meeting of the IHMF (International Herpes Management Forum).
    Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.
    Martin JM, Danziger-Isakov LA.
    Pediatr Transplant; 2011 May; 15(3):229-36. PubMed ID: 21199215
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 May; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 5. [Prophylaxis against Epstein Barr disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Catalán P, Alba A.
    Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S29-31. PubMed ID: 23282553
    [Abstract] [Full Text] [Related]

  • 6. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K.
    Transpl Infect Dis; 2010 Aug 01; 12(4):322-9. PubMed ID: 20487414
    [Abstract] [Full Text] [Related]

  • 7. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N.
    Clin Infect Dis; 2001 Mar 01; 32(5):742-51. PubMed ID: 11229841
    [Abstract] [Full Text] [Related]

  • 8. High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation.
    Hazar V, Kansoy S, Küpesiz A, Aksoylar S, Kantar M, Yeşilipek A.
    Bone Marrow Transplant; 2004 May 01; 33(9):931-5. PubMed ID: 15034541
    [Abstract] [Full Text] [Related]

  • 9. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
    Griffiths P, Whitley R, Snydman DR, Singh N, Boeckh M, International Herpes Management Forum.
    Herpes; 2008 Oct 01; 15(1):4-12. PubMed ID: 18983762
    [Abstract] [Full Text] [Related]

  • 10. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
    Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.
    Transpl Infect Dis; 2000 Sep 01; 2(3):112-7. PubMed ID: 11429021
    [Abstract] [Full Text] [Related]

  • 11. [Prophylaxis against respiratory viral disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Álvarez AM, Catalán P, Alba A, Zubleta M.
    Rev Chilena Infectol; 2012 Sep 01; 29 Suppl 1():S33-6. PubMed ID: 23282554
    [Abstract] [Full Text] [Related]

  • 12. The value of pre-emptive therapy for cytomegalovirus after liver transplantation.
    Müller V, Perrakis A, Meyer J, Förtsch T, Korn K, Croner RS, Yedibela S, Hohenberger W, Schellerer VS.
    Transplant Proc; 2012 Jun 01; 44(5):1357-61. PubMed ID: 22664015
    [Abstract] [Full Text] [Related]

  • 13. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS, Preiser W, Kottaridis PD, McKeag N, Brink NS, Tedder RS, Goldstone AH, Linch DC, Mackinnon S.
    Br J Haematol; 2000 Dec 01; 111(3):782-90. PubMed ID: 11122138
    [Abstract] [Full Text] [Related]

  • 14. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 15. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients.
    Bonon SH, Menoni SM, Rossi CL, De Souza CA, Vigorito AC, Costa DB, Costa SC.
    J Infect; 2005 Feb 01; 50(2):130-7. PubMed ID: 15667914
    [Abstract] [Full Text] [Related]

  • 16. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB, Cooney E, van de Ven C, Della-Lotta P, Cairo MS.
    Pediatr Blood Cancer; 2007 Sep 01; 49(3):306-12. PubMed ID: 16972242
    [Abstract] [Full Text] [Related]

  • 17. [Special considerations in the management of cytomegalovirus infection in pediatric solid organ transplant recipients].
    Rumbao J, Frauca E.
    Enferm Infecc Microbiol Clin; 2011 Dec 01; 29 Suppl 6():70-3. PubMed ID: 22541928
    [Abstract] [Full Text] [Related]

  • 18. CMV infection, diagnosis and antiviral strategies after liver transplantation.
    Lautenschlager I.
    Transpl Int; 2009 Nov 01; 22(11):1031-40. PubMed ID: 19619175
    [Abstract] [Full Text] [Related]

  • 19. [Prophylaxis against Toxoplasma gondii disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Payá E, Noemí I, Tassara R, Catalán P, Avilés CL.
    Rev Chilena Infectol; 2012 Sep 01; 29 Suppl 1():S37-9. PubMed ID: 23282555
    [Abstract] [Full Text] [Related]

  • 20. [Prophylaxis against Chagas disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
    Benítez R, Noemí I, Tassara R, Catalán P, Avilés CL.
    Rev Chilena Infectol; 2012 Sep 01; 29 Suppl 1():S41-3. PubMed ID: 23282556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.